Literature DB >> 19020112

Abnormal immunological profile and vaginal microbiota in women prone to urinary tract infections.

Pirkka V Kirjavainen1, Stephen Pautler, Miren L Baroja, Kingsley Anukam, Kate Crowley, Kristine Carter, Gregor Reid.   

Abstract

The host determinants of susceptibility to recurrent urinary tract infections (UTI) are poorly understood. We investigated whether the susceptibility is associated with abnormalities in the immunological defense and further explored the linkage to vaginal microbiota. For this purpose, we compared vaginal, urine, and blood samples collected during a disease-free period from 22 women with recurrent UTI and from 17 controls. In UTI-prone women, interleukin-12 (IL-12) production in peripheral monocytes and myeloid dendritic cells (DCs) was significantly (P < 0.05) enhanced whether measured in relative numbers of IL-12-producing cells or in mean IL-12 production per cell. In contrast, no T-cell polarization was observed. Interestingly, it seemed that the cytokine production of DCs and monocytes did not translate into T-cell activation in the UTI-prone group in a manner similar to that seen with the controls. In vaginal mucosa, UTI-prone women had a lower concentration of tissue repair-associated vascular endothelial growth factor (VEGF) (P = 0.006) and less often had detectable amounts of the chief monocyte and DC chemoattractant, monocyte chemotactic protein 1 (P = 0.005), than the controls. The microbiota of UTI-prone women was characterized by a diminished lactobacillus morphotype composition, with an abnormally high (>3) mean Nugent score of 4.6 compared to 1.7 for the controls (P = 0.003). Normal lactobacillus composition was associated with increased IL-17 and VEGF concentrations in vaginal mucosa. In conclusion, immunological defects and a persistently aberrant microbiota, a lack of lactobacilli in particular, may contribute to susceptibility to recurrent UTI. Further studies of antigen-presenting-cell function and T-cell activation in recurrent UTI are called for.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020112      PMCID: PMC2620669          DOI: 10.1128/CVI.00323-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  48 in total

1.  Evaluation of a familial predisposition to recurrent urinary tract infections in women.

Authors:  W J Hopkins; D T Uehling; D S Wargowski
Journal:  Am J Med Genet       Date:  1999-04-23

Review 2.  Innate immunity and angiogenesis.

Authors:  Stefan Frantz; Karen A Vincent; Olivier Feron; Ralph A Kelly
Journal:  Circ Res       Date:  2005-01-07       Impact factor: 17.367

3.  The bacterial flora of the vaginal vestibule, urethra and vagina in premenopausal women with recurrent urinary tract infections.

Authors:  A Pfau; T Sacks
Journal:  J Urol       Date:  1981-11       Impact factor: 7.450

4.  Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification.

Authors:  E R Boskey; K M Telsch; K J Whaley; T R Moench; R A Cone
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

Review 6.  Pathogenesis of urinary tract infections with normal female anatomy.

Authors:  Gal Finer; Daniel Landau
Journal:  Lancet Infect Dis       Date:  2004-10       Impact factor: 25.071

7.  Elevated interleukin-8 levels in the urine of patients with urinary tract infections.

Authors:  Y C Ko; N Mukaida; S Ishiyama; A Tokue; T Kawai; K Matsushima; T Kasahara
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

8.  Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections.

Authors:  K Gupta; A E Stapleton; T M Hooton; P L Roberts; C L Fennell; W E Stamm
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

9.  Recurring urinary tract infection: incidence and risk factors.

Authors:  B Foxman
Journal:  Am J Public Health       Date:  1990-03       Impact factor: 9.308

Review 10.  Human CD4+CD25+ regulatory T cells.

Authors:  Clare Baecher-Allan; Vissia Viglietta; David A Hafler
Journal:  Semin Immunol       Date:  2004-04       Impact factor: 11.130

View more
  24 in total

Review 1.  The Vaginal Microbiota and Urinary Tract Infection.

Authors:  Ann E Stapleton
Journal:  Microbiol Spectr       Date:  2016-12

Review 2.  Obstetric and gynecological diseases and complications resulting from vaginal dysbacteriosis.

Authors:  Stefan Miladinov Kovachev
Journal:  Microb Ecol       Date:  2014-04-08       Impact factor: 4.552

3.  The future of research in female pelvic medicine.

Authors:  Jamie Chao; Toby C Chai
Journal:  Curr Urol Rep       Date:  2015-02       Impact factor: 3.092

Review 4.  Non-antibiotic Approaches to Preventing Pediatric UTIs: a Role for D-Mannose, Cranberry, and Probiotics?

Authors:  Christina B Ching
Journal:  Curr Urol Rep       Date:  2022-04-20       Impact factor: 3.092

Review 5.  Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.

Authors:  Amelia E Barber; J Paul Norton; Travis J Wiles; Matthew A Mulvey
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-02       Impact factor: 11.056

6.  Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections.

Authors:  Rebecca M Brotman; Jacques Ravel; Patrik M Bavoil; Patti E Gravitt; Khalil G Ghanem
Journal:  Vaccine       Date:  2013-10-14       Impact factor: 3.641

7.  Vaginal microbiota and the use of probiotics.

Authors:  Sarah Cribby; Michelle Taylor; Gregor Reid
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-03-29

8.  Pyrosequencing analysis of the human microbiota of healthy Chinese undergraduates.

Authors:  Zongxin Ling; Xia Liu; Yueqiu Luo; Li Yuan; Karen E Nelson; Yuezhu Wang; Charlie Xiang; Lanjuan Li
Journal:  BMC Genomics       Date:  2013-06-10       Impact factor: 3.969

9.  Preventive effects of Lactobacillus mixture on experimental E. coli urinary tract infection in infant rats.

Authors:  Jung Won Lee; Jee Hyun Lee; Sun Hee Sung; Seung Joo Lee
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

Review 10.  The Mammalian Metaorganism: A Holistic View on How Microbes of All Kingdoms and Niches Shape Local and Systemic Immunity.

Authors:  Solveig Runge; Stephan Patrick Rosshart
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.